Status:
TERMINATED
ESWT for UE Pain in Patients With Cervical Spinal Cord Injury
Lead Sponsor:
Bundang CHA Hospital
Conditions:
Spastic Tetraplegia
Pain
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This study aimed to investigate the efficacy and safety of extracorporeal shockwave therapy (ESWT) for upper extremity pain related to spasticity in patients with spinal cord injury.
Detailed Description
6 times of ESWT (3,000 pulses per time, low energy under 0.3 mJ/m\^2, tolerable range) on forearm area to reduce pain related to spasticity in patients with cervical myelopathy
Eligibility Criteria
Inclusion
- Spinal cord damage confirmed in the spinal cord image
- 1 month after spinal cord injury
- Spasticity of upper extremities
- Pain in areas below spinal cord injury more than 4 points on the numerical scale (NRS)
- Cognitive functions that can clearly point out NRS with more than 15 points in the mini mental state examination (MMSE)
- Age: 20 and older
- Person who has agreed in writing to decide his or her participation and comply with the precautions
Exclusion
- Pain due to trauma
- Injection treatments two weeks before participating in the study
- Severe coagulopathy (excluding antiplatelet use)
- Impaired cognition
Key Trial Info
Start Date :
June 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2021
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04319679
Start Date
June 5 2020
End Date
April 13 2021
Last Update
April 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Rehabilitation Medicine, CHA Bundang Medical Center,
Seongnam, South Korea, 13496